Effects of Lactobacillus kefiranofaciens M1 isolated from kefir grains on enterohemorrhagic Escherichia coli infection using mouse and intestinal cell models

Journal of Dairy Science

Volumn 96, Issue 12, 2013, Pages 7467-7477

  Chen, Y P ^a   Lee, T Y ^a   Hong, W S ^a   Hsieh, H H ^a   Chen, M J ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Enterohemorrhagic Escherichia coli; Kefir; Lactobacillus kefiranofaciens M1; Probiotic

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LACTOBACILLUS; LACTOBACILLUS KEFIRANOFACIENS; MUS;

PROBIOTIC AGENT;

ANIMAL; BAGG ALBINO MOUSE; CACO 2 CELL LINE; DAIRY PRODUCT; DRUG SCREENING; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMAN; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; LACTOBACILLUS; METABOLISM; MICROBIOLOGY; MOUSE; ORGANISMAL INTERACTION; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CACO-2 CELLS; CULTURED MILK PRODUCTS; DRUG EVALUATION, PRECLINICAL; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; INTESTINAL MUCOSA; LACTOBACILLUS; MICE; MICE, INBRED BALB C; MICROBIAL INTERACTIONS; PROBIOTICS;

EID: 84888039434     PISSN: 00220302     EISSN: 15253198     Source Type: Journal    
DOI: 10.3168/jds.2013-7015     Document Type: Article

References (36)

1. Calderon Toledo C.C., Rogers T.J., Svensson M., Tati R., Fischer H., Svanborg C., Karpman D. Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7. Am. J. Pathol 2008, 173:1428-1439.
2. Cario E., Gerken G., Podolsky D.K. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 2004, 127:224-238.
3. Cario E., Gerken G., Podolsky D.K. Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology 2007, 132:1359-1374.
4. Chen H.-C., Wang S.-Y., Chen M.-J. Microbiological study of lactic acid bacteria in kefir grains by culture-dependent and culture-independent methods. Food Microbiol 2008, 25:492-501.
5. Chen Y.P., Hsiao P.J., Hong W.S., Dai T.Y., Chen M.J. Lactobacillus kefiranofaciens M1 isolated from milk kefir grains ameliorates experimental colitis in vitro and in vivo. J. Dairy Sci 2012, 95:63-74.
6. Cook D.N., Prosser D.M., Forster R., Zhang J., Kuklin N.A., Abbondanzo S.J., Niu X.-D., Chen S.-C., Manfra D.J., Wiekowski M.T., Sullivan L.M., Smith S.R., Greenberg H.B., Narula S.K., Lipp M., Lira S.A. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 2000, 12:495-503.
7. Dieleman L.A., Palmen M.J.H.J., Akol H., Bloemena E., Peña A.S., Meuwissen S.G.M., Van Rees E.P. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin. Exp. Immunol 1998, 114:385-391.
8. DuPont A.W., DuPont H.L. The intestinal microbiota and chronic disorders of the gut. Nat. Rev. Gastroenterol. Hepatol 2011, 8:523-531.
9. Eaton K.A., Honkala A., Auchtung T.A., Britton R.A. Probiotic Lactobacillus reuteri ameliorates disease due to enterohemorrhagic Escherichia coli in germfree mice. Infect. Immun 2011, 79:185-191.
10. Etienne-Mesmin L., Chassaing B., Sauvanet P., Denizot J., Blanquet-Diot S., Darfeuille-Michaud A., Pradel N., Livrelli V. Interactions with M cells and macrophages as key steps in the pathogenesis of enterohemorragic Escherichia coli infections. PLoS ONE 2011, 6:e23594.
11. Gagnon M., Kheadr E.E., Dabour N., Richard D., Fliss I. Effects of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice. Int. J. Food Microbiol 2006, 111:26-33.
12. Gareau M.G., Sherman P.M., Walker W.A. Probiotics and the gut microbiota in intestinal health and disease. Nat. Rev. Gastroenterol. Hepatol 2010, 7:503-514.
13. Gibson D.L., Ma C., Rosenberger C.M., Bergstrom K.S.B., Valdez Y., Huang J.T., Khan M.A., Vallance B.A. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cell. Microbiol 2008, 10:388-403.
14. Guzel-Seydim Z.B., Kok-Tas T., Greene A.K., Seydim A.C. Review: Functional properties of kefir. Crit. Rev. Food Sci. Nutr 2011, 51:261-268.
15. Hodges K., Gill R. Infectious diarrhea: Cellular and molecular mechanisms. Gut Microbes 2010, 1:4-21.
16. Hong W.-S., Chen H.-C., Chen Y.-P., Chen M.-J. Effects of kefir supernatant and lactic acid bacteria isolated from kefir grain on cytokine production by macrophage. Int. Dairy J 2009, 19:244-251.
17. Hong W.-S., Chen Y.-P., Chen M.-J. The antiallergic effect of kefir lactobacilli. J. Food Sci 2010, 75:H244-H253.
18. Hong W.-S., Chen Y.-P., Dai T.-Y., Huang I.-N., Chen M.-J. Effect of heat-inactivated kefir-isolated Lactobacillus kefiranofaciens M1 on preventing an allergic airway response in mice. J. Agric. Food Chem 2011, 59:9022-9031.
19. Johnson-Henry K.C., Donato K.A., Shen-Tu G., Gordanpour M., Sherman P.M. Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function. Infect. Immun 2008, 76:1340-1348.
20. Kaper J.B., Nataro J.P., Mobley H.L.T. Pathogenic Escherichia coli. Nat. Rev. Microbiol 2004, 2:123-140.
21. Lim J.Y., Yoon J.W., Hovde C.J. A brief overview of Escherichia coli O157:H7 and its plasmid O157. J. Microbiol. Biotechnol 2010, 20:5-14.
22. Mohawk K.L., Melton-Celsa A.R., Zangari T., Carroll E.E., O'Brien A.D. Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora. Microb. Pathog 2010, 48:131-142.
23. Mohawk K.L., O'Brien A.D. Mouse models of Escherichia coli O157:H7 infection and Shiga toxin injection. J. Biomed. Biotechnol 2011, 2011:258185.
24. Nishikawa K., Matsuoka K., Kita E., Okabe N., Mizuguchi M., Hino K., Miyazawa S., Yamasaki C., Aoki J., Takashima S., Yamakawa Y., Nishijima M., Terunuma D., Kuzuhara H., Natori Y. A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7. Proc. Natl. Acad. Sci. USA 2002, 99:7669-7674.
25. Podolsky D.K., Gerken G., Eyking A., Cairo E. Colitis-associated variant of TLR2 causes impaired mucosal repair because of TFF3 deficiency. Gastroenterology 2009, 137:209-220.
26. Putaala H., Salusjärvi T., Nordström M., Saarinen M., Ouwehand A.C., Hansen E.B., Rautonen N. Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression. Res. Microbiol 2008, 159:692-698.
27. Santos A., San Mauro M., Sanchez A., Torres J.M., Marquina D. The antimicrobial properties of different strains of Lactobacillus spp. isolated from kefir. Syst. Appl. Microbiol 2003, 26:434-437.
28. Serna A., Boedeker E.C. Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections. Curr. Opin. Gastroenterol 2008, 24:38-47.
29. Shang L., Fukata M., Thirunarayanan N., Martin A.P., Arnaboldi P., Maussang D., Berin C., Unkeless J.C., Mayer L., Abreu M.T., Lira S.A. TLR signaling in small intestinal epithelium promotes B cell recruitment and IgA production in lamina propria. Gastroenterology 2008, 135:529-538.
30. TM) against Escherichia coli O157:H7 infection in mice. FEMS Immunol. Med. Microbiol 2002, 34:59-64.
31. Strugnell R.A., Wijburg O.L.C. The role of secretory antibodies in infection immunity. Nat. Rev. Microbiol 2010, 8:656-667.
32. Tarr P.I., Gordon C.A., Chandler W.L. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005, 365:1073-1086.
33. Tsai Y.-T., Cheng P.-C., Pan T.-M. Immunomodulating activity of Lactobacillus paracasei subsp. paracasei NTU 101 in enterohemorrhagic Escherichia coli O157:H7-infected mice. J. Agric. Food Chem 2010, 58:11265-11272.
34. Wang S.Y., Chen H.C., Liu J.R., Lin Y.C., Chen M.J. Identification of yeasts and evaluation of their distribution in Taiwanese kefir and viili starters. J. Dairy Sci 2008, 91:3798-3805.
35. West A.P., Brodsky I.E., Rahner C., Woo D.K., Erdjument-Bromage H., Tempst P., Walsh M.C., Choi Y., Shadel G.S., Ghosh S. TLR signaling augments macrophage bactericidal activity through mitochondrial ROS. Nature 2011, 472:476-480.
36. Zhang X., Cheng Y., Xiong Y., Ye C., Zheng H., Sun H., Zhao H., Ren Z., Xu J. Enterohemorrhagic Escherichia coli specific enterohemolysin induced IL-1β in human macrophages and EHEC-induced IL-1β required activation of NLRP3 inflammasome. PLoS ONE 2012, 7:e50288.